share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4：持股變動聲明-高管 Marriott Tina
美股sec公告 ·  06/29 05:19
牛牛AI助理已提取核心訊息
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on June 27, 2024. The transaction was executed at a price of $7.215 per share, resulting in a total market value of $43,290. Following the sale, Marriott's direct holdings in the company amount to 535,457 shares. The sale was conducted on the open market and coincided with the exercise of derivative securities, where Marriott acquired an equivalent number of shares at $1.06 each on the same day.
Recursion Pharmaceuticals的總裁兼COO Tina Marriott於2024年6月27日出售了6,000股該公司A類普通股，交易價格爲每股7.215美元，總市值爲43,290美元。在出售後，Marriott在該公司直接擁有的股份爲535,457股。該銷售是在公開市場上進行的，並與衍生證券的行使同時進行，在同一天以1.06美元的價格獲得了相等數量的股票。
Recursion Pharmaceuticals的總裁兼COO Tina Marriott於2024年6月27日出售了6,000股該公司A類普通股，交易價格爲每股7.215美元，總市值爲43,290美元。在出售後，Marriott在該公司直接擁有的股份爲535,457股。該銷售是在公開市場上進行的，並與衍生證券的行使同時進行，在同一天以1.06美元的價格獲得了相等數量的股票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。